These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7687774)

  • 1. [Preparation of concentrated grafts of healthy CD34 hematopoietic stem cells and performance of autografts in hematology].
    Gorin NC; Lopez M; Douay L; Laporte JP; Lesage S; Stachowiack J; Isnard F; Najman A
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):287-9. PubMed ID: 7687774
    [No Abstract]   [Full Text] [Related]  

  • 2. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis.
    Gandhi M; Jestice H; Scott M; Bloxham D; Bass G; Craig J; Marcus R
    Bone Marrow Transplant; 1999 Aug; 24(4):369-75. PubMed ID: 10467325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric detection of growth factor receptors in autografts and analysis of growth factor concentrations in autologous stem cell transplantation: possible significance for platelet recovery.
    Schiødt I; Jensen CH; Kjaersgaard E; Gaarsdal E; Nikolajsen K; Johnsen HE
    Bone Marrow Transplant; 2000 Sep; 26(5):525-31. PubMed ID: 11019842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
    Dyson PG; Horvath N; Joshua D; Barrow L; Van Holst NG; Brown R; Gibson J; To LB
    Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
    Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
    Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.
    Pico JL; Bourhis JH; Bennaceur AL; Beaujean F; Bayle C; Ibrahim A; Girinski T; Hayat M; Dighiero G; Tchernia G
    Nouv Rev Fr Hematol (1978); 1995; 37(6):381-3. PubMed ID: 8907636
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.
    Johnson RJ; Owen RG; Smith GM; Child JA; Galvin M; Newton LJ; Rawstron A; Major K; Woodhead V; Robinson F; Jack A; Morgan GJ
    Bone Marrow Transplant; 1996 May; 17(5):723-7. PubMed ID: 8733688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stem cells in hematology and oncology].
    Goldschmidt H; Egerer G; Fruehauf S; Ho AD
    Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of peripheral blood hematopoietic progenitor cell level of 5/mm3 versus 50/mm3 as a surrogate marker to initiate efficient autologous blood stem cell collection.
    Kim MK; Kim S; Jang G; Lee SS; Sym SJ; Lee DH; Kim SW; Jang S; Park CJ; Chi HS; Huh J; Suh C
    J Clin Apher; 2007; 22(5):277-82. PubMed ID: 17880017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of CD34+ hematopoietic precursors: clinical rationale.
    Berenson RJ
    Transplant Proc; 1992 Dec; 24(6):3032-4. PubMed ID: 1281584
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
    Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous peripheral blood selected CD34+ cell transplantation in the treatment of multiple myeloma].
    Tang X; Morineau N; Milpied N; Moreau P; Bataille R; Harousseau JL
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):370-3. PubMed ID: 11877101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.